E-aid Cognitive Behavior Therapy for Insomnia to Prevent Transition From Acute Insomnia to Chronic Insomnia in China
A Randomized Controlled Study of E-aid Cognitive Behavior Therapy in Patients With Acute Insomnia to Prevent Transition to Chronic Insomnia
1 other identifier
interventional
192
1 country
1
Brief Summary
Acute insomnia is one of the most common sleep disorders. Online cognitive behavioral therapy for insomnia (e-aid Cognitive Behavioral Therapy for Insomnia, eCBTI) has received wide attention in recent years. Foreign countries already have some eCBTI treatment tool, shown similar efficacy as standard CBTI, but how eCBTI can help in acute insomnia require further exploration and examination. In this study, Investigators will establish eCBTI treatment tool to test whether eCBTI can reduce the conversion of acute insomnia to chronic insomnia disorder; and whether they can improve insomnia symptoms, sleep-related symptoms, anxiety and depressive symptoms, and quality of life
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2017
CompletedFirst Posted
Study publicly available on registry
October 5, 2017
CompletedStudy Start
First participant enrolled
November 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 2, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 2, 2019
CompletedOctober 20, 2020
June 1, 2020
1.6 years
September 25, 2017
October 16, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of chronic insomnia
the diagnostic criteria for chronic insomnia disorder according to DSM-5
3 months
Secondary Outcomes (9)
Changes in Ford Insomnia Response to Stress Test (FIRST)
baseline and 3 months
Changes in Short Form 12-Item Health Survey version 2(SF-12v2)
baseline and 3 months
Changes in Sleep Hygiene and Practices Scale(SHPS)
baseline and 3 months
Changes in Pre-Sleep Arousal Scale(PSAS)
baseline and 3 months
Changes in Epworth Sleepiness Scale(ESS)
baseline and 3 months
- +4 more secondary outcomes
Study Arms (2)
eCBTI
EXPERIMENTALThis group will receive a 1-week of eCBTI treatment and will receive 3 months of follow-up.
Control
NO INTERVENTIONThis group does not receive any interventions during first 3 months of clinical study. If the participants still have no remission from insomnia after 3 months, will be recommended to enter the standardized insomnia treatment (medication and / or non-drug treatment).
Interventions
The brief eCBTI contains a one-week core course: sleep hygiene education, sleep restriction, stimulus control, relaxation audios, cognitive components, information about sleeping pills, and a brief overview. In addition, individual customized sleep restriction and stimulation control treatments were provided according to the subject's previous 2-week sleep status.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis for acute insomnia according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5);
- Must be eighteen years or older;
- Must be able to comply with the intervention;
- Must be able to provide informed consent;
- Owning smart devices (such as smartphones and tablets).
You may not qualify if:
- A significant untreated mental or medical illness (e.g. consciousness disturbances, mania, acute phase of schizophrenia, major depressive disorder);
- Received any kind of psychological treatment for insomnia in the past 6 months;
- Shift workers, frequent cross-time flyers (e.g. shifted nurse/health professionals, international flight crew).
- To allow for greater generalisability, this study does not exclude patients with a stable condition of somatic disease, mental disorders (eg, depression in remission), or individuals receiving pharmacological treatments (eg, antihypertensive drugs, antidepressants and benzodiazepines).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
Related Publications (1)
Yang Y, Luo X, Paudel D, Zhang J, Li SX, Zhang B. Effects of e-aid cognitive behavioural therapy for insomnia (eCBTI) to prevent the transition from acute insomnia to chronic insomnia: study protocol for a randomised controlled trial. BMJ Open. 2019 Nov 18;9(11):e033457. doi: 10.1136/bmjopen-2019-033457.
PMID: 31740476DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bin Zhang, MD & PhD
Nanfang Hospital, Southern Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The independent researcher from the IT department who carries out the randomisation and allocation procedure will be blinded to the study protocol. Participants could not be blinded to treatment allocation as participants in the control group did not receive any intervention from this trial. The research team will have limited contact with both IT staff and study participants, therefore, will not be able to bias the allocation or the assessments. Statistical analyses will be carried out by an independent researcher from the Southern Medical University who is not involved with the randomisation and assessment procedures.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 25, 2017
First Posted
October 5, 2017
Study Start
November 1, 2017
Primary Completion
June 2, 2019
Study Completion
June 2, 2019
Last Updated
October 20, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share